Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Shailly Gupta Price announced by @TBAlliance for a six-month treatment course for #tuberculosis drug pretomanid at US$364 is still too high: says @SharonannMSF @MSF_access at 50th @UnionConference in Hyderabad msfaccess.org/price-announce… 00:53 - 29 Oct 2019